Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; dermatology products; generic pharmaceutical products; and dentistry products. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Bausch Health Companies Inc.

Brand House Collective ( ($TBHC) ) just unveiled an announcement. Following the closing of a merger effective April 2, 2026, Brand House Collective...

Brand House Collective Completes Merger and Nasdaq Delisting

Brand House Collective ( ($TBHC) ) just unveiled an update. On March 26, 2026, The Brand House Collective disclosed that it had received a Nasdaq n...

Brand House Collective Faces Nasdaq Listing Compliance Challenge

Pathfinder Bancorp ( ($PBHC) ) has issued an announcement. On March 30, 2026, Pathfinder Bancorp, Inc. announced that its board declared a cash div...

Pathfinder Bancorp Declares Quarterly Cash Dividend for Shareholders

Kirkland’s (($TBHC)) has held its Q4 earnings call. Read on for the main highlights of the call. Kirkland’s latest earnings call painted a cautious...

Kirkland’s Earnings Call: Progress Shadowed by Tariff Risks

Brand House Collective ( ($TBHC) ) has issued an announcement. The Brand House Collective, Inc. reported that Chief Operating Officer James E. Schi...

Current Quarter	$0.81	Next Quarter	$0.94
Current Year	$4.15	Next Year	$3.81
QoQ Growth	+16.0%	YoY Growth	-8.2%
3Y EPS CAGR	+63.3%	Target Price	$7.67
Consensus	Buy	Upside	+45.8%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BHC	$5.26	0.00%	1.20M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BHC	$5.26	0%	1.20M
3
4
5
6

BHC

BHC

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Bausch Health Companies Inc. Data in Excel

Get Bausch Health Companies Inc. Data in Excel